Fractalkine receptor

Hatori K, Nagai A, Heisel R, Ryu JK, Kim SU (2002) Fractalkine and fractalkine receptors in human neurons and gfial cells. J Neurosci Res 69 418 26 Herzberg U, Sagen J (2001) Peripheral nerve exposure to HIV viral envelope protein gpl20 induces neuropathic pain and spinal gliosis. J Neuroimmunol 116 29-39... [Pg.186]

Hatoii K, Nagai A, Heisel R et al (2002) Eractalkine and fractalkine receptors in human neurons and glial cells. J Neurosci Res 69 418-426... [Pg.314]

Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, Huang D, Kidd G, Dombrowski S, Dutta R, Lee JC, Cook DN, Jung S, Lira SA, Liftman DR, Ransohoff RM (2006) Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosd... [Pg.367]

Imai T, Hieshima K, Haskell C, et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997 91 521-530. [Pg.85]

Feng L, Chen S, Garcia GE, et al. Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication. Kidney Int 1999 56 612-620. [Pg.85]

Lucas AD, Bursill C, Guzik TJ, Sadowski J, Channon KM, Greaves DR. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1). Circulation 2003 108(20) 2498-2504. [Pg.225]

Moatti D, Faure S, Fumeron F, et al. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 2001 97(7) 1925-1928. [Pg.227]

Ghilardi G, Biondi ML, Turri O, Guagnellini E, Scorza R. Internal carotid artery occlusive disease and polymorphisms of fractalkine receptor CX3CR1 a genetic risk factor. Stroke 2004 35(6) 1276-1279. [Pg.227]

Direct evidence of a neuronal-microglia communication mechanism through the fractalkine system came from in vivo experiments using CX3CR1-deficient mice showing that neuronal-derived fractalkine and its interaction with fractalkine receptor plays a critical role in tonic inhibition of microglial mediated neurotoxicity (66). In three clinically relevant models—CNS response to systemic inflammation, the l-methyl-4 phenyl-1,2,3,6 tetra-hydropyridine (MPTP)... [Pg.361]

Jung S, Aliberti J, Graemmel P, et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 2000 20 4106 U14. [Pg.364]

Cardona A, Pioro EP, Sasse ME, et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 2006 9 917-924. [Pg.367]

Cybulsky MI, Hegele RA. The fractalkine receptor CX3CR1 is a key mediator of atherogenesis. J Clin Invest 2003 111 1118-1120. [Pg.367]

Imai, T., Hieshima, K., Haskell, C., Baba, M., Nagira, M., Nishimura, M., Kakizaki, M., Takagi, S., Nomiyama, H., Schall, T. J., and Yoshie, O. (1997) Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91, 521-530. [Pg.32]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...